Skandinaviska Enskilda Banken (SEB)’s Impax Laboratories, Inc. IPXL Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-94,200	Closed	-$1.57M	–	733
2017 Q4	$1.57M	Buy	+94,200	New	+$1.73M	0.01%	505
2017 Q3	–	Sell	-11,000	Closed	-$177K	–	755
2017 Q2	$177K	Sell	11,000 -26,800	-71%	-$396K	﹤0.01%	741
2017 Q1	$478K	Sell	37,800 -255,300	-87%	-$3.08M	﹤0.01%	667
2016 Q4	$3.88M	Buy	293,100 +86,700	+42%	+$1.48M	0.05%	267
2016 Q3	$4.89M	Buy	206,400 +30,200	+17%	+$812K	0.05%	264
2016 Q2	$5.08M	Buy	176,200 +14,900	+9%	+$486K	0.06%	245
2016 Q1	$5.17M	Sell	161,300 -31,000	-16%	-$1.09M	0.06%	237
2015 Q4	$8.22M	Buy	+192,300	New	+$7.68M	0.11%	145

Other funds holding IPXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s IPXL Position: Q1 2018 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 94,200 shares — an estimated $1.57M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in IPXL in Q4 2015 and held it in 8 quarters. The position peaked at $8.22M in Q4 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

Skandinaviska Enskilda Banken (SEB) reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 94,200 Impax Laboratories, Inc. shares in Q1 2018, an estimated $1.57M.
Skandinaviska Enskilda Banken (SEB) first reported a position in Impax Laboratories, Inc. in Q4 2015 and held it in 8 quarters.
Skandinaviska Enskilda Banken (SEB)'s Impax Laboratories, Inc. position peaked at $8.22M in Q4 2015.
188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2018, filed 30 Apr 2018.